Topical Treatments for Plaque Psoriasis: Options, Usage Strategies, and Realistic Expectations

Topical Treatments for Plaque Psoriasis: Options, Usage Strategies, and Realistic Expectations

Topicals remain first-line for limited plaque psoriasis (BSA <10%). Understanding the options optimizes adherence and outcomes.

Agent Classes and Key Characteristics

ClassExamplesMechanismVehicle OptionsBest ForMain Side Effects
CorticosteroidsClobetasol, betamethasone, triamcinolone, hydrocortisoneAnti-inflammatory, vasoconstrictiveOintment > cream > lotion > foam > spray > shampooRapid flare control; thick plaques (super-high potency)Atrophy, striae, telangiectasia, HPA suppression (high potency/large BSA)
Vitamin D analogsCalcipotriene, calcitriolNormalize keratinocyte differentiationCream, ointment, foam, solutionMaintenance; combo with steroids; face/intertriginousIrritation, hypercalcemia (rare, >100g/wk)
RetinoidsTazarotene 0.05–0.1%Modulate keratinization, inflammationCream, gel, foamThick plaques; combo with steroids (↑ efficacy, ↓ irritation)Irritation, photosensitivity, teratogenic (Category X)
Calcineurin inhibitorsTacrolimus 0.1%, pimecrolimus 1%T-cell inhibitionOintment, creamFace, folds, genital; steroid-sparingBurning, pruritus; lymphoma warning (theoretical)
PDE4 inhibitorRoflumilast 0.3% cream↑ cAMP → ↓ inflammatory cytokinesCreamMild-moderate; intertriginous; non-steroidalDiarrhea (systemic absorption minimal)
TYK2 inhibitorDeucravacitinib cream (investigational)Selective TYK2 → ↓ IL-23/Th17CreamEmerging non-steroidal optionApplication site reactions
Salicylic acid 2–6%KerolyticDesquamationShampoo, solution, ointmentScalp, thick scale removalIrritation, salicylism (large BSA)
Coal tar 0.5–5%Anti-proliferative, anti-inflammatoryShampoo, cream, ointment, bath oilScalp, maintenance; inexpensiveOdor, staining, folliculitis, photosensitivity
Anthralin 0.1–1%Anti-proliferativeCream, ointmentResistant plaques; short-contact therapyStaining, irritation (short-contact minimizes)

Optimization Strategies

  • Combination > monotherapy: Steroid + vitamin D analog (calcipotriene/betamethasone fixed combo) = gold standard.
  • Vehicle matters: Ointments > creams for penetration; foams/sprays for scalp/body; patient preference drives adherence.
  • Pulse therapy: High-potency steroid 2 weeks on / 2 weeks off (or weekends only) → maintains efficacy, minimizes atrophy.
  • Sequential therapy: Steroid induction → vitamin D/retinoid/calcineurin maintenance.

When to Escalate

  • No improvement after 8–12 weeks of optimal topical therapy.
  • BSA >10% or sensitive areas uncontrolled.
  • Significant QoL impact (DLQI >10).
  • PsA symptoms.

Topicals are not "weak"—they're precision tools. Master them before escalating.

Skin Conditions - Related Articles